Home | About Us | Glossary | Contact Us | Select your country / language

DUROLANE is now approved for all sizes of joints

Effective long term relief from joint pain
with one, safe drug free treatment

Osteoarthritis (OA) is the most common cause of knee and hip pain. OA can affect young and old alike but more often affects people over the age of 40 - predominantly those that have been active and those that still are.

If you suffer from arthritis you will be all too familiar with the range of symptoms that it causes and their effect upon your life.

The potential benefits of DUROLANE for OA sufferers include:

Directly treats the affected joint
Repeatable as required by your physician
May help to avoid or delay hip or knee
replacement surgery
Long-term freedom from osteoarthritis pain
Simple & quick to administer
Drug-free alternative to pills

DUROLANE has been developed specifically to treat the symptoms of osteoarthritis in the knee and hip. It works by restoring the lubricating and shock-absorbing properties of joint fluid, which are depleted in osteoarthritis.

DUROLANE is a registered trademark of Q-MED AB.
NASHA is a trademark of Q-MED AB.
The Bioventus logo is a registered trademark of Bioventus LLC. © 2012 Bioventus LLC

Indications

For the symptomatic treatment of mild to moderate osteoarthritis.

DUROLANE (3ml): Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been approved in the EU for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, toes, and the temporomandibular and facet joints.

DUROLANE SJ (1ml): Symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, elbow, wrist, fingers, toes, and the temporomandibular and facet joints.

Both DUROLANE and DUROLANE SJ are also indicated for pain following joint arthroscopy either in the presence of osteoarthritis or subsequent to general surgical repair within 3 months of the procedure.

There are no known contraindications.

You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/or stiffness at the injection site. Clinical effectiveness has been demonstrated out to 6 months but results may vary depending on various patient factors.

Effective long term relief from joint pain with one, safe drug free treatment

Effective long term relief from joint pain
with one, safe drug free treatment